Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Explore the detailed record of transactions filed by Baffa Raffaele, Directeur Médical. Insider active across 1 company, notably Ziopharm Oncology INC. Cumulatively, 1 reports have been published. History available since 17 May 2021. The latest transaction was filed on 17 May 2021 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration
Raffaele Baffa is the Chief Medical Officer at ZIOPHARM Oncology Inc., a biopharmaceutical company specializing in cancer treatment. In this role, he oversees clinical and research initiatives, contributing to innovation in oncology treatments.